Mohit obtained his Master's in Biotechnology in New Delhi and a PG diploma in Bioinformatics ‘A’ level. He worked as a Junior Research Fellow at the International Center for Genetic Engineering and Biotechnology (ICGEB) in the Recombinant Gene Products lab led by Dr. Navin Khanna. He moved to Germany to pursue his PhD in the lab of Prof. Hermann Schindelin where he worked at the apex of the ubiquitylation pathway exploring the structure-function relationship of the ubiquitin-activating enzyme (Uba1) and its interactions with multiple E2 enzymes. In addition, he established the structural basis of the variable potency of adenosyl sulfamate inhibitors towards Uba1 which hold promise for cancer therapy. After a brief postdoc in Würzburg, Mohit moved to Frankfurt to join the Dikic lab to pursue his fascination for novel chemistry of ubiquitylation discovered in Legionella. In May 2020, Mohit started team leader position in conjunction with EUbOPEN IMI/ SGC Frankfurt to target the ubiquitin system with new probes in order to develop therapeutics for human diseases.